Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does SACUBITRIL\VALSARTAN Cause Benign prostatic hyperplasia? 34 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 34 reports of Benign prostatic hyperplasia have been filed in association with SACUBITRIL\VALSARTAN. This represents 0.0% of all adverse event reports for SACUBITRIL\VALSARTAN.

34
Reports of Benign prostatic hyperplasia with SACUBITRIL\VALSARTAN
0.0%
of all SACUBITRIL\VALSARTAN reports
0
Deaths
23
Hospitalizations

How Dangerous Is Benign prostatic hyperplasia From SACUBITRIL\VALSARTAN?

Of the 34 reports, 23 (67.6%) required hospitalization, and 1 (2.9%) were considered life-threatening.

Is Benign prostatic hyperplasia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SACUBITRIL\VALSARTAN. However, 34 reports have been filed with the FAERS database.

What Other Side Effects Does SACUBITRIL\VALSARTAN Cause?

Hypotension (11,718) Death (9,605) Dyspnoea (8,952) Dizziness (8,548) Fatigue (8,172) Wrong technique in product usage process (8,022) Cough (7,743) Weight decreased (5,030) Cardiac failure (4,504) Malaise (4,299)

What Other Drugs Cause Benign prostatic hyperplasia?

TADALAFIL (596) TAMSULOSIN (304) FINASTERIDE (266) PANTOPRAZOLE (261) PREDNISONE (257) ALBUTEROL (254) ASPIRIN (243) TIOTROPIUM (235) RAMIPRIL (193) AMLODIPINE (179)

Which SACUBITRIL\VALSARTAN Alternatives Have Lower Benign prostatic hyperplasia Risk?

SACUBITRIL\VALSARTAN vs SAFINAMIDE SACUBITRIL\VALSARTAN vs SAIZEN SACUBITRIL\VALSARTAN vs SALICYLATE SACUBITRIL\VALSARTAN vs SALICYLIC ACID SACUBITRIL\VALSARTAN vs SALMETEROL

Related Pages

SACUBITRIL\VALSARTAN Full Profile All Benign prostatic hyperplasia Reports All Drugs Causing Benign prostatic hyperplasia SACUBITRIL\VALSARTAN Demographics